Receive a FREE Mesothelioma Treatment
Information Packet

Mesothelioma

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

 

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

Background:
RATIONALE: Radiofrequency ablation uses high-frequency electric current to kill tumor cells. CT-guided radiofrequency ablation may be effective treatment for lung cancer. This is a Phase II trial to study the effectiveness of radiofrequency ablation in treating patients who have refractory or advanced lung cancer.

Objectives:

Determine the safety and toxicity of radiofrequency ablation in patients with refractory or advanced pulmonary malignancies.
Determine the efficacy of this treatment, in terms of local control, in these patients.
Determine whether CT scan is a reasonable imaging assessment tool for treatment delivery and follow-up in these patients.

Location/Contact Information:
California
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, 90095-1781, United States;
Recruiting
Robert D. Suh, MD 310-794-2168
Study chairs or principal investigators
Robert D. Suh, MD, Study Chair
Jonsson Comprehensive Cancer Center